tradingkey.logo

Artivion Inc

AORT
39.590USD
+0.120+0.30%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
1.88BMarktkapitalisierung
VerlustKGV TTM

Artivion Inc

39.590
+0.120+0.30%

mehr Informationen über Artivion Inc Unternehmen

Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons’ challenges in treating patients with aortic diseases. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. It has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.

Artivion Inc Informationen

BörsenkürzelAORT
Name des UnternehmensArtivion Inc
IPO-datumFeb 12, 1993
CEOMackin (James Patrick)
Anzahl der mitarbeiter1600
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 12
Addresse1655 Roberts Boulevard N W
StadtKENNESAW
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl30144
Telefon17704193355
Websitehttps://artivion.com/
BörsenkürzelAORT
IPO-datumFeb 12, 1993
CEOMackin (James Patrick)

Führungskräfte von Artivion Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
174.43K
-5000.00%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
150.06K
+6325.00%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
149.90K
+6325.00%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
129.84K
+6325.00%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
125.79K
-5322.00%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
121.36K
+11125.00%
Mr. James W. Bullock
Mr. James W. Bullock
Independent Director
Independent Director
68.65K
+6325.00%
Mr. Jeffrey H. (Jeff) Burbank
Mr. Jeffrey H. (Jeff) Burbank
Lead Independent Director
Lead Independent Director
53.80K
+6325.00%
Mr. Matthew A. (Matt) Getz
Mr. Matthew A. (Matt) Getz
Vice President - Human Resources
Vice President - Human Resources
34.12K
-9420.00%
Mr. Andrew M. Green
Mr. Andrew M. Green
Vice President - Regulatory Affairs
Vice President - Regulatory Affairs
33.50K
-7618.00%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. John E. Davis
Mr. John E. Davis
Senior Vice President - Global Sales and Marketing
Senior Vice President - Global Sales and Marketing
174.43K
-5000.00%
Mr. Daniel J. Bevevino
Mr. Daniel J. Bevevino
Independent Director
Independent Director
150.06K
+6325.00%
Mr. Thomas F. Ackerman
Mr. Thomas F. Ackerman
Independent Director
Independent Director
149.90K
+6325.00%
Mr. Jon W. Salveson
Mr. Jon W. Salveson
Independent Director
Independent Director
129.84K
+6325.00%
Ms. Amy D. Horton, CPA
Ms. Amy D. Horton, CPA
Chief Accounting Officer, Vice President
Chief Accounting Officer, Vice President
125.79K
-5322.00%
Mr. Lance A. Berry, CPA
Mr. Lance A. Berry, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
Chief Financial Officer, Chief Operating Officer, Executive Vice President - Finance, Treasurer
121.36K
+11125.00%

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Aortic stent grafts
39.59M
34.91%
On X
26.80M
23.63%
Preservation Services
25.72M
22.69%
Bio Glue
18.89M
16.66%
Surgical sealants
18.89M
16.66%
Other
2.39M
2.11%
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Aortic stent grafts
39.59M
34.91%
On X
26.80M
23.63%
Preservation Services
25.72M
22.69%
Bio Glue
18.89M
16.66%
Surgical sealants
18.89M
16.66%
Other
2.39M
2.11%

Aktionärsstatistik

Aktualisiert: Sun, Nov 16
Aktualisiert: Sun, Nov 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
11.85%
The Vanguard Group, Inc.
6.67%
Fidelity Management & Research Company LLC
6.00%
Nomura Investment Management Business Trust
5.24%
Perceptive Advisors LLC
4.26%
Andere
65.98%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
11.85%
The Vanguard Group, Inc.
6.67%
Fidelity Management & Research Company LLC
6.00%
Nomura Investment Management Business Trust
5.24%
Perceptive Advisors LLC
4.26%
Andere
65.98%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
52.94%
Investment Advisor/Hedge Fund
28.30%
Individual Investor
4.29%
Private Equity
4.26%
Hedge Fund
3.33%
Research Firm
1.87%
Pension Fund
1.06%
Bank and Trust
0.34%
Sovereign Wealth Fund
0.04%
Andere
3.58%

Institutionelle Beteiligung

Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
410
43.29M
91.25%
+30.07K
2025Q3
417
43.26M
91.49%
+621.40K
2025Q2
388
42.72M
90.85%
+749.95K
2025Q1
378
41.65M
93.88%
+1.56M
2024Q4
361
38.77M
90.20%
+1.92M
2024Q3
344
36.62M
88.99%
+563.89K
2024Q2
325
36.03M
88.04%
+491.62K
2024Q1
322
35.76M
90.55%
-2.03M
2023Q4
321
34.94M
89.27%
+12.56K
2023Q3
319
34.91M
90.03%
-219.54K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
5.61M
11.85%
+69.64K
+1.26%
Sep 30, 2025
The Vanguard Group, Inc.
3.02M
6.38%
+232.42K
+8.34%
Sep 30, 2025
Fidelity Management & Research Company LLC
2.84M
6%
+642.73K
+29.25%
Sep 30, 2025
Nomura Investment Management Business Trust
2.48M
5.24%
-472.72K
-15.99%
Sep 30, 2025
Perceptive Advisors LLC
2.02M
4.26%
-773.70K
-27.69%
Sep 30, 2025
Morgan Stanley Smith Barney LLC
1.87M
3.94%
-64.00K
-3.31%
Sep 30, 2025
State Street Investment Management (US)
1.54M
3.25%
+25.42K
+1.68%
Sep 30, 2025
Wellington Management Company, LLP
1.50M
3.17%
-212.34K
-12.39%
Sep 30, 2025
Juniper Investment Company, LLC
1.33M
2.82%
-530.76K
-28.47%
Sep 30, 2025
Fred Alger Management, LLC
1.32M
2.78%
-33.71K
-2.50%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
AAM Sawgrass US Small Cap Quality Growth ETF
4.14%
Unusual Whales Subversive Democratic Trading ETF
3.4%
ROBO Global Healthcare Technology & Innovation ETF
1.85%
State Street SPDR S&P Health Care Equipment ETF
1.74%
Invesco S&P SmallCap Health Care ETF
1.15%
Invesco Dorsey Wright Healthcare Momentum ETF
0.76%
Invesco S&P SmallCap 600 Pure Growth ETF
0.69%
First Trust Small Cap Growth AlphaDEX Fund
0.64%
Invesco Dorsey Wright SmallCap Momentum ETF
0.42%
iShares Micro-Cap ETF
0.33%
Mehr Anzeigen
AAM Sawgrass US Small Cap Quality Growth ETF
Anteil4.14%
Unusual Whales Subversive Democratic Trading ETF
Anteil3.4%
ROBO Global Healthcare Technology & Innovation ETF
Anteil1.85%
State Street SPDR S&P Health Care Equipment ETF
Anteil1.74%
Invesco S&P SmallCap Health Care ETF
Anteil1.15%
Invesco Dorsey Wright Healthcare Momentum ETF
Anteil0.76%
Invesco S&P SmallCap 600 Pure Growth ETF
Anteil0.69%
First Trust Small Cap Growth AlphaDEX Fund
Anteil0.64%
Invesco Dorsey Wright SmallCap Momentum ETF
Anteil0.42%
iShares Micro-Cap ETF
Anteil0.33%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI